Vertebral Compression Fracture Devices

Vertebral Compression Fracture Devices

Global Vertebral Compression Fracture Devices Market to Reach US$1.4 Billion by 2030

The global market for Vertebral Compression Fracture Devices estimated at US$968.3 Million in the year 2023, is expected to reach US$1.4 Billion by 2030, growing at a CAGR of 5.3% over the analysis period 2023-2030. Balloon Kyphoplasty, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$1.2 Billion by the end of the analysis period. Growth in the Vertebroplasty segment is estimated at 4.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$260.9 Million While China is Forecast to Grow at 8.8% CAGR

The Vertebral Compression Fracture Devices market in the U.S. is estimated at US$260.9 Million in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$304.1 Million by the year 2030 trailing a CAGR of 8.8% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.7% and 5.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.8% CAGR.

Vertebral Compression Fracture Devices - Key Trends and Drivers

Vertebral compression fracture (VCF) devices are essential tools in the management and treatment of spinal fractures, particularly those resulting from osteoporosis, trauma, or metastatic disease. These fractures occur when the vertebral body in the spine collapses, leading to severe pain, reduced mobility, and potential deformity of the spine. The primary aim of VCF devices is to stabilize the fracture, alleviate pain, and restore the vertebral height and function to as close to normal as possible. The most commonly used VCF devices include vertebroplasty and kyphoplasty kits. Vertebroplasty involves the injection of bone cement into the fractured vertebra to stabilize it, whereas kyphoplasty includes the additional step of inflating a balloon inside the vertebra to create a cavity before cement injection, which helps in restoring some of the lost vertebral height. These minimally invasive procedures have become increasingly popular due to their ability to provide immediate pain relief and improve patient outcomes with shorter recovery times compared to traditional surgical methods, making them an attractive option for both patients and healthcare providers.

The application of VCF devices spans a diverse patient demographic, from the elderly suffering from osteoporosis to younger individuals with traumatic spinal injuries or cancer-related bone weakening. The rising incidence of osteoporosis, particularly among the aging population, is a significant driver of the demand for VCF treatments. As the population ages, the prevalence of conditions that contribute to bone weakening, such as osteoporosis, continues to rise, increasing the need for effective treatment options. Advancements in imaging technologies, such as magnetic resonance imaging (MRI) and computed tomography (CT) scans, have greatly improved the diagnosis and management of vertebral fractures, allowing for more precise and effective interventions. The integration of advanced biomaterials in bone cement and the development of new delivery systems have further enhanced the safety and efficacy of these procedures. Moreover, the increasing awareness of the benefits of early intervention in vertebral fractures has led to a higher adoption rate of VCF devices among healthcare providers. The introduction of navigational tools and robotics in spinal surgeries also holds significant promise for more precise placement of these devices, potentially improving outcomes and reducing the risk of complications associated with these procedures.

The growth in the vertebral compression fracture devices market is driven by several factors. Technological advancements have played a crucial role, with innovations in biomaterials and the development of more sophisticated delivery systems significantly enhancing the performance and safety of VCF procedures. These advancements have made the procedures more effective and accessible, thereby expanding their use. The increasing prevalence of osteoporosis and other conditions that weaken bones is expanding the addressable market for these devices, as more individuals require treatment for these debilitating fractures. Moreover, the aging global population, coupled with the consequent rise in age-related spinal conditions, serves as a significant driver of market demand. Healthcare providers are increasingly favoring minimally invasive procedures due to their associated benefits, such as reduced hospital stays, lower risk of infections, and quicker recovery times, which propel the adoption of VCF devices. Additionally, the improved diagnostic capabilities afforded by advanced imaging technologies have led to more timely and accurate treatments, enhancing patient outcomes. Favorable reimbursement policies for minimally invasive spine procedures and the development of cost-effective treatment options are also contributing to market growth. As these trends continue to evolve, the demand for vertebral compression fracture devices is expected to rise, fostering further innovation and development in the field, ensuring that patients have access to the most effective and advanced treatment options available.

Select Competitors (Total 14 Featured) -

• Alphatec Spine, Inc.
• Benvenue Medical, Inc.
• Globus Medical, Inc.
• Johnson & Johnson
• Medtronic PLC
• Stryker Corporation
• Vexim SA
• Zimmer Biomet Holdings, Inc.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.